About this product

This Haemophilus parasuis inactivated vaccine, fortified with a propolis adjuvant, is a crucial biological product designed for the prevention of *Haemophilus parasuis* infections in swine. The propolis adjuvant significantly enhances the vaccine's immunogenicity, leading to a more robust and prolonged immune response in vaccinated animals. Key performance characteristics include its ability to stimulate high levels of protective antibodies against *Haemophilus parasuis* serotypes, thereby reducing the incidence and severity of respiratory disease and polyserositis commonly associated with this pathogen. The vaccine is manufactured using advanced inactivation techniques to ensure safety and efficacy, with a focus on high-quality antigen preparation and adjuvant formulation. While specific material compositions are proprietary, the manufacturing process adheres to stringent veterinary biological product standards. This product is typically supplied in standard veterinary vaccine packaging, with various volume options available to suit different herd sizes. Its primary applications are within the swine farming industry, targeting producers seeking to improve herd health and reduce economic losses due to *Haemophilus parasuis*. This vaccine is ideal for importers, wholesalers, and large-scale livestock operations looking to secure reliable disease prevention solutions. Its efficacy and safety profile make it a valuable commodity for international trade, offering a proven method to safeguard swine populations against a significant bacterial threat.